TTD | Drug: D0R8JK

Drug General Information
Drug ID	D0R8JK
Former ID	DNC009660
Drug Name	N-phenyl-6-(sulfamoylamino)hexanamide
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[529866]
Structure		Download 2D MOL 3D MOL
Formula	C12H19N3O3S
Canonical SMILES	C1=CC=C(C=C1)NC(=O)CCCCCNS(=O)(=O)N
InChI	1S/C12H19N3O3S/c13-19(17,18)14-10-6-2-5-9-12(16)15-11-7-3-1-4-8-11/h1,3-4,7-8,14H,2,5-6,9-10H2,(H,15,16)(H2,13,17,18)
InChIKey	GJBBLVDVDAQQMI-UHFFFAOYSA-N
PubChem Compound ID	25216937
Target and Pathway
Target(s)	Histone deacetylase 6	Target Info	Inhibitor	[529866]
KEGG Pathway	Alcoholism
KEGG Pathway	Viral carcinogenesis
Pathway Interaction Database	Signaling events mediated by HDAC Class II
Pathway Interaction Database	Signaling events mediated by HDAC Class I
Reactome	NOTCH1 Intracellular Domain Regulates Transcription
	Constitutive Signaling by NOTCH1 PEST Domain Mutants
	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
	Assembly of the primary cilium
WikiPathways	Ectoderm Differentiation
	Neural Crest Differentiation
	Cell Cycle
References
Ref 529866	Bioorg Med Chem Lett. 2009 Jan 15;19(2):336-40. Epub 2008 Nov 27.Sulfamides as novel histone deacetylase inhibitors.
Ref 529866	Bioorg Med Chem Lett. 2009 Jan 15;19(2):336-40. Epub 2008 Nov 27.Sulfamides as novel histone deacetylase inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information